Published in Life Sci on October 20, 1986
Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. Proc Natl Acad Sci U S A (1994) 2.34
Cell adhesion molecules in chemically-induced renal injury. Pharmacol Ther (2007) 1.06
Direct antiangiogenic actions of cadmium on human vascular endothelial cells. Toxicol In Vitro (2007) 0.88
Isolation and identification of metallothionein isoforms (MT-1 and MT-2) in the rat testis. Biochem J (1998) 0.86
Analysis of the effects of overexpression of metallothionein-I in transgenic mice on the reproductive toxicology of cadmium. Environ Health Perspect (1996) 0.83
Long-lasting morphofunctional remodelling of liver parenchyma and stroma after a single exposure to low and moderate doses of cadmium in rats. Int J Exp Pathol (2013) 0.80
Distribution of metallothionein in normal and pathological human skin. Arch Dermatol Res (1994) 0.78
Effects of cadmium exposure on medaka (Oryzias latipes) testes. J Toxicol Pathol (2017) 0.75
Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients. J Neurol Sci (2001) 1.64
Fatigue in multiple sclerosis: cross-sectional correlation with brain MRI findings in 71 patients. Neurology (1999) 1.59
Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult Scler (2000) 1.54
MRI findings in 32 consecutive lipomas using conventional and advanced sequences. J Neuroimaging (1999) 1.48
Isolation of cadmium-binding proteins. Experientia (1971) 1.30
The biosynthesis of metallothionein rat liver and kidney after administration of cadmium. Chem Biol Interact (1976) 1.17
Brain MRI lesions and atrophy are related to depression in multiple sclerosis. Neuroreport (2000) 1.15
Metabolism of intravenously injected cadmium-binding protein. Biochem Biophys Res Commun (1975) 1.10
Cadmium and zinc binding in mammalian liver and kidneys. Arch Environ Health (1972) 1.08
Cadmium and zinc in pregnancy and lactation. Arch Environ Health (1972) 1.02
MRI T2 shortening ('black T2') in multiple sclerosis: frequency, location, and clinical correlation. Neuroreport (2000) 0.99
Thrombotic thrombocytopenic purpura: brain CT and MRI findings in 12 patients. Neurology (1999) 0.97
Lead nephrotoxicity and associated disorders: biochemical mechanisms. Toxicology (1992) 0.97
Differences in cadmium and mercury uptakes by hepatocytes: role of calcium channels. Toxicol Appl Pharmacol (1991) 0.93
Elevated urinary excretion of metallothionein due to environmental cadmium exposure. Toxicology (1981) 0.93
Metallothionein in the extracellular fluids as an index of cadmium toxicity. Environ Health Perspect (1979) 0.93
Cytotoxicity of cadmium and characteristics of its transport in cardiomyocytes. Toxicol Appl Pharmacol (1999) 0.92
Metallothionein in plasma and urine of cadmium-exposed rats determined by a single-antibody radioimmunoassay. Fundam Appl Toxicol (1983) 0.92
Sex differences in hepatic and renal cadmium accumulation and metallothionein induction. Role of estradiol. Biochem Pharmacol (1991) 0.91
The mechanisms of hepatic and renal metallothionein biosynthesis in cadmium-exposed rats. Chem Biol Interact (1977) 0.90
Cadmium uptake by primary cultures of rat renal cortical epithelial cells: influence of cell density and other metal ions. Toxicol Appl Pharmacol (1993) 0.89
Biological differences in cadmium and zinc turnover. Arch Environ Health (1972) 0.87
Metallothionein excretion in urine upon cadmium exposure: its relationship with liver and kidney cadmium. Toxicology (1981) 0.87
Urinary metallothionein and tissue metal levels of rats injected with cadmium, mercury, lead, copper or zinc. Toxicology (1983) 0.86
Nephrotoxicity of cadmium-metallothionein: protection by zinc and role of glutathione. Toxicol Appl Pharmacol (1998) 0.86
Metallothionein as a storage protein for cadmium: its toxicological implications. Dev Toxicol Environ Sci (1982) 0.85
Cross-reactivity of metallothioneins from different origins with rabbit anti-rat hepatic metallothione in antibody. Biochem Biophys Res Commun (1978) 0.84
Occupational exposure to cadmium: effect on metallothionein and other biological indices of exposure and renal function. Arch Toxicol (1987) 0.82
Cadmium and mercury accumulation in rat hepatocytes: interactions with other metal ions. Toxicol Appl Pharmacol (1992) 0.82
Urinary metallothionein as a new index of renal dysfunction in "Itai-Itai" disease patients and other Japanese women environmentally exposed to cadmium. Arch Toxicol (1982) 0.81
Renal cortical mitochondrial dysfunction upon cadmium metallothionein administration to Sprague-Dawley rats. J Toxicol Environ Health A (2001) 0.81
Uptake and binding of cadmium and mercury to metallothionein in rat hepatocyte primary cultures. Biochem J (1982) 0.81
An evaluation of tissue metallothionein and genetic resistance to cadmium toxicity in mice. Toxicol Appl Pharmacol (1986) 0.80
Decreased uptake and altered subcellular disposition of testicular cadmium as possible mechanisms of resistance to cadmium-induced testicular necrosis in inbred mice. Toxicology (1984) 0.80
Dose-response relationship between urinary cadmium and metallothionein in a Japanese population environmentally exposed to cadmium. Toxicology (1991) 0.79
Early-onset Moyamoya syndrome in a patient with Down syndrome: case report and review of the literature. J Child Neurol (2000) 0.79
Cadmium as a trace element and cadmium binding components in human cells. Experientia (1970) 0.79
Urinary metallothionein as an indicator of cadmium body burden and of cadmium-induced nephrotoxicity. Environ Health Perspect (1984) 0.79
Dose-response relationship between total cadmium intake and metallothioneinuria using logistic regression analysis. Toxicology (1993) 0.79
Dose-response relationship between dietary cadmium intake and metallothioneinuria in a population from a cadmium-polluted area of Japan. Toxicology (1991) 0.79
Application of path analysis to urinary findings of cadmium-induced renal dysfunction. J Environ Sci Health A Tox Hazard Subst Environ Eng (2001) 0.78
Determination of metallothionein in tissues by radioimmunoassay and by cadmium saturation method. Anal Biochem (1986) 0.78
Dose-response relationship between total cadmium intake and prevalence of renal dysfunction using general linear models. J Appl Toxicol (1995) 0.78
Developmental and sex differences in cadmium distribution and metallothionein induction and localization. J Appl Toxicol (1988) 0.78
Biological indicators of cadmium exposure and toxicity. Experientia Suppl (1986) 0.78
Dose-effect relationship between ethyl alcohol pretreatment and retention and tissue distribution of mercury vapor in rats. J Pharmacol Exp Ther (1982) 0.77
Measurement of cadmium-induced metallothionein in urine by ELISA and prevention of overestimation due to polymerization. J Anal Toxicol (1999) 0.77
The low molecular weight cadmium-, mercury- and zinc-binding proteins (metallothioneins): biosynthesis, metabolism, and possible role in metal toxicity. Experientia Suppl (1979) 0.77
Resistance to cadmium-induced necrosis in testes of inbred mice: possible role of a metallothionein-like cadmium-binding protein. Toxicol Appl Pharmacol (1985) 0.77
Radioimmunoassay for metallothionein in body fluids and tissues. Methods Enzymol (1991) 0.77
The nephrotoxicity of intravenously administered cadmium-metallothionein: effect of dose, mode of administration, and preexisting renal cadmium burden. Toxicol Appl Pharmacol (1994) 0.76
Differences in the uptake of cadmium and mercury by rat hepatocyte primary cultures. Role of a sulfhydryl carrier. Biochem Pharmacol (1984) 0.76
Metabolism of orally ingested cadmium in humans. Dev Toxicol Environ Sci (1980) 0.76
Mercury uptake by LLC-PK1 cells: dependence on temperature and membrane potential. Toxicol Appl Pharmacol (1997) 0.75
Comparison of cadmium, mercury and calcium accumulations by isolated hepatocytes of the small skate (Raja erinacea) and rat. Comp Biochem Physiol C (1992) 0.75
Mercury uptake by primary cultures of rat renal cortical epithelial cells. II. Effects of pH, halide ions, and alkali metal ions. Toxicol Appl Pharmacol (1995) 0.75
Subchronic treatment of rats with aurothioglucose; effects on plasma, hepatic, renal and urinary zinc, copper and metallothionein. Toxicology (1987) 0.75
Biological indicators of cadmium exposure and toxicity. Experientia (1984) 0.75
Mercury uptake by primary cultures of rat renal cortical epithelial cells. I. Effects of cell density, temperature, and metabolic inhibitors. Toxicol Appl Pharmacol (1995) 0.75
Induction of metallothionein in rat tissues following subchronic exposure to mercury shown by radioimmunoassay. Biol Trace Elem Res (1987) 0.75
Comparison of cadmium-saturation assay and radioimmunoassay for the determination of metallothionein concentration in tissues. Experientia Suppl (1987) 0.75
Dose-response relationship for renal dysfunction in a population environmentally exposed to cadmium. IARC Sci Publ (1992) 0.75